Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-08-09
2011-08-09
Spector, Lorraine (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S001100, C514S021300, C514S021100, C435S069200, C435S069700, C530S324000, C530S400000, C530S407000, C530S350000
Reexamination Certificate
active
07994136
ABSTRACT:
A novel metalloproteinase inhibitor, analogs thereof, polynucleotides encoding the same, and methods of production, are disclosed. Pharmaceutical compositions and methods of treating disorders caused by excessive amounts of metalloproteinase are also disclosed.
REFERENCES:
Docherty et al “Sequence of Human Tissue Inhibitor of Metalloproteinases and its Identity to Erythroid-Potentiating Activity” Nature v.318, 66-69 (Nov. 1985).
Murray et al “Purification and Partial Amino Acid Sequence of a Bovine Cartilage-Derived Collagenase Inhibitor” J. Biol. Chem. v.261 (9) pp. 4154-4159. (Mar. 1986).
Bethesda Research Laboratories 1985 Catalog. p. 62.
Boone Thomas C.
DeClerck Yves A.
Langley Keith E.
Amgen Inc.
Klaniecki James E.
Spector Lorraine
LandOfFree
Metalloproteinase inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metalloproteinase inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metalloproteinase inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2641683